NCT03019042 is a NA clinical trial of Hou Gu Mi Xi in Gastrointestinal Disease, sponsored by Jiangxi University of Traditional Chinese Medicine.

Who is sponsoring NCT03019042?

NCT03019042 is sponsored by Jiangxi University of Traditional Chinese Medicine.

What drugs are being tested in NCT03019042?

Interventions in NCT03019042: Hou Gu Mi Xi, placebo.

What condition does NCT03019042 study?

NCT03019042 studies Gastrointestinal Disease.

Is NCT03019042 still recruiting?

NCT03019042 is currently completed. Last updated 11 May 2020.

Last reviewed 2020-05-11 · How we verify

NCT03019042

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Non-organic Gastrointestinal Disorders

Completed NA Last updated 11 May 2020

What this trial tests

NA trial testing Hou Gu Mi Xi in Gastrointestinal Disease in 200 participants. Completed in 10 July 2019.

Timeline

15 November 2016

Primary endpoint
10 July 2018

10 July 2019

Quick facts

Lead sponsor	Jiangxi University of Traditional Chinese Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	200
Start date	15 November 2016
Primary completion	10 July 2018
Estimated completion	10 July 2019
Sites	1 location across China

Drugs / interventions tested

Hou Gu Mi Xi
placebo

Conditions studied

Gastrointestinal Disease — all drugs for Gastrointestinal Disease →

Sponsor

Jiangxi University of Traditional Chinese Medicine

Who can join

Adults 14 to 120, any sex, with Gastrointestinal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial aims to determine whether Hou Gu Mi Xi is an effective treatment for improving symptoms and indicators in patients with spleen qi deficiency and mild gastrointestinal disorder.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo-Controlled Trial.
Chen X, Nie H, Liu W, Zhou X, et al · · 2018 · cited 2× · PMID 30622590 · DOI 10.1155/2018/1980491

Verify or expand the search:

Other trials of Hou Gu Mi Xi

Trials testing the same drug.

NCT03320538 — Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases · NA · completed
NCT03025152 — Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer · NA · terminated

Other recruiting trials for Gastrointestinal Disease

Currently open trials in the same condition.

NCT05053191 — Advancing Nursing Practices in Hospital Oncology Care · NA · active not recruiting
NCT04949282 — Spanish Series of Patients Treated With the Radionuclide Lutetium177 · recruiting
NCT03566160 — Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy · NA · active not recruiting

Other Jiangxi University of Traditional Chinese Medicine trials

Trials by the same sponsor.

NCT07535983 — Bushen Yiqi Formula Combined With Dehydroepiandrosterone in Women With Diminished Ovarian Reserve · Phase 1, PHASE2 · recruiting
NCT07079085 — Safety Evaluation of Pueraria Lobata Radix in Specific Consumption Scenarios for Type 2 Diabetes · not yet recruiting
NCT06611332 — Efficacy and Safety of Electroacupuncture on Lumbar Disc Herniation with Radiculopathy · NA · not yet recruiting
NCT06494683 — Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus · NA · recruiting
NCT05976308 — Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome · Phase 1, PHASE2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03019042 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jiangxi University of Traditional Chinese Medicine
Last refreshed: 11 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03019042.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing